NEW YORK, Dec. 17, 2020 /PRNewswire/ — Every year, 40 million American adults suffer from some form of depression, says the Anxiety and Depression Association of America (ADAA). The rising incidence of such lifestyle-associated diseases is expected to propel the North American aromatherapy market from $763.7 million in 2019 to $1,639.9 million by 2030, at a 7.6% CAGR between 2020 and 2030, according to P&S Intelligence.
Similarly, insomnia is seen in almost 30% of the regional population, as per the National Sleep Foundation. Apart from insomnia and depression, the North American aromatherapy market is also growing on account of the rising number of people suffering from respiratory diseases, mental illnesses, and allergies. Aromatherapy, in particular essential oils, is rapidly gaining popularity in the continent for relieving stress, anxiety, and depression.
